The Pharmaceutical Research and Manufacturers of America spent nearly $38 million on lobbying last year, the highest annual ...

Jan 23 (Reuters) - Cipla, India's third-largest drugmaker by revenue, reported a 57% quarterly profit decline on Friday as the company deals with a production halt at the exclusive manufacturer of its ...

US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of more than $20bn in what would be the latest big deal in the red-hot ...

Jan 23 (Reuters) - Cipla, India's third-largest drugmaker by revenue, reported quarterly profit below estimates on Friday, dragged by a production halt at the exclusive manufacturer of its no. 2 ...

The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...

The stock surged about 18% on Monday to 55.2 Hong Kong dollars, after the biotech firm said it completed the first patient first dose of Garutadustat. The drug is a treatment for inflammatory bowel ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...

Roche Holding shares rose 2.1% Wednesday after the Swiss drugmaker reported positive results from a new study of an experimental breast cancer drug. The pill, giredestrant, reduced the risk of death ...

Pfizer (PFE) is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and ...